| 2026-04-01 |
详情>>
内部人交易：
Fishman Peter L.股份增加125.00股
|
| 2026-03-02 |
详情>>
股本变动：
变动后总股本2080.40万股
|
| 2026-03-02 |
详情>>
业绩披露：
2025年年报每股收益-0.09美元,归母净利润-3879.8万美元,同比去年增长52.79%
|
| 2026-02-25 |
财报披露：
美东时间 2026-02-25 盘前发布财报
|
| 2025-10-29 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.09美元,归母净利润-3757.4万美元,同比去年增长-11.94%
|
| 2025-07-30 |
详情>>
业绩披露：
2025年中报每股收益-0.07美元,归母净利润-2983.6万美元,同比去年增长-253.88%
|
| 2025-05-07 |
详情>>
业绩披露：
2025年一季报每股收益-0.04美元,归母净利润-1569.7万美元,同比去年增长-57.71%
|
| 2025-04-11 |
复牌提示：
2025-04-10 19:50:00 停牌，复牌日期 2025-04-11 09:00:00
|
| 2025-04-10 |
股东大会：
将于2025-05-13召开股东大会
会议内容 ▼▲
- 1.Ordinary resolution to re-elect Mr. Aaron Berg as a director;
2.Ordinary resolution to re-elect Ms. Patrice Bonfiglio as a director;
3.Ordinary resolution to re-elect Mr. Paul Cohen, M.D. as a director;
4.Ordinary resolution to re-elect Mr. Keith L. Horn as a director;
5.Ordinary resolution to re-elect Mr. Odysseas Kostas, M.D. as a director;
6.Ordinary resolution to re-elect Mr. Oliver O'Connor as a director;
7.Ordinary resolution to re-elect Mr. Louis Sterling III as a director;
8.Ordinary resolution to re-elect Ms. Diane E. Sullivan as a director;
9.Ordinary resolution to hold an advisory (non-binding) vote to approve the compensation of the Company’s “named executive officers” as described in full in the “Executive Compensation Discussion and Analysis” section, the tabular disclosure regarding such compensation, and the accompanying narrative disclosure on pages 26 to 58 of the accompanying Proxy Statement;
10.Ordinary resolution to appoint Ernst & Young LLP as auditors of the Company to hold office until the conclusion of the next general meeting at which annual accounts are laid before the Company and to authorize the Audit Committee of the Board of Directors of the Company to agree the auditors’ remuneration as described in full on pages 11 to 12 of the accompanying Proxy Statement;
11.Ordinary resolution to generally and unconditionally authorize the Board of Directors of the Company (the "Board") to allot shares in the Company or grant rights to subscribe for or to convert any security into shares of the Company up to an aggregate nominal amount of ￡38,400,000 (which is equal to approximately 18% of the existing issued share capital) as described in full on pages 13 to 14 of the accompanying Proxy Statement;
12.Special resolution to give power to the Board, subject to the passing of Resolution No. 11 above and in accordance with Section 570 of the Companies Act 2006, to allot equity securities (as defined in Section 560 of the Companies Act) pursuant to the authority conferred upon them by Resolution No. 11, as if Section 561(1) of the Companies Act did not apply to any such allotment, provided that the power hereby conferred shall (a) be limited to the allotment of equity securities up to an aggregate nominal amount of ￡21,330,000 (being the aggregate nominal amount of ￡18,770,400 in respect of Ordinary Shares and ￡2,559,600 in respect of Preference Shares); and (b) expire on the 18-month anniversary of the date on which this resolution is passed (unless renewed, varied or revoked by the Company prior to or on that date), except that the Company may, before such expiration, make an offer or agreement which would, or might, require equity securities to be alloted after the expiration of such period and the directors may allot equity securities in pursuance of any such offer or agreement notwithstanding that the authority conferred by this resolution has expired;
13.Ordinary resolution to re-elect Mr. Michael Torok as a director.
|
| 2025-04-10 |
详情>>
拆分方案：
每20.0000合并分成1.0000股
|
| 2025-03-12 |
详情>>
业绩披露：
2022年年报每股收益-0.26美元,归母净利润-1.06亿美元,同比去年增长-1468.91%
|
| 2025-03-12 |
详情>>
业绩披露：
2024年年报每股收益-0.2美元,归母净利润-8218.3万美元,同比去年增长-39.03%
|
| 2024-10-30 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.08美元,归母净利润-3356.5万美元,同比去年增长37.06%
|
| 2024-10-30 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.13美元,归母净利润-5333.1万美元,同比去年增长50.00%
|
| 2024-07-31 |
详情>>
业绩披露：
2024年中报每股收益-0.02美元,归母净利润-843.1万美元,同比去年增长75.22%
|
| 2024-05-01 |
详情>>
业绩披露：
2024年一季报每股收益-0.02美元,归母净利润-995.3万美元,同比去年增长39.53%
|
| 2024-03-04 |
股东大会：
将于2024-04-18召开股东大会
会议内容 ▼▲
- 1.Ordinary Resolution: to re-elect Mr. Patrick Holt as a director;
2.Ordinary Resolution: to re-elect Mr. Louis Sterling III as a director;
3.Ordinary Resolution: to re-elect Ms. Patrice Bonfiglio as a director;
4.Ordinary Resolution: to hold an advisory (non-binding) vote to approve the compensation of the Company’s “named executive officers” as described in full in the “Executive Compensation Discussion and Analysis” section, the tabular disclosure regarding such compensation, and the accompanying narrative disclosure on pages 32 to 62 of the accompanying Proxy Statement;
5.Ordinary Resolution: to appoint Ernst & Young LLP as auditors of the Company to hold office until the conclusion of the next general meeting at which annual accounts are laid before the Company and to authorize the Audit Committee of the Board of Directors of the Company to agree the auditors’ remuneration as described in full on page 10 of the accompanying Proxy Statement;
6.Ordinary Resolution: to adopt and approve the proposed amendment to the Company’s 2020 Stock Incentive Plan as described on pages 12 to 19 of the accompanying Proxy Statement;
7.Special Resolution: to authorize and approve that, subject to the confirmation of the High Court of Justice in England and Wales, the amount standing to the credit of the share premium account of the Company as at the date of the court hearing be cancelled (the "Reduction of Capital");
|
| 2024-02-29 |
详情>>
业绩披露：
2023年年报每股收益-0.15美元,归母净利润-5911.2万美元,同比去年增长44.13%
|
| 2023-05-26 |
股东大会：
将于2023-06-21召开股东大会
会议内容 ▼▲
- 1.To re-elect Mr. O’Connor as a director;
2.To re-elect Mr. DiPaolo as a director;
3.To re-elect Dr. Kostas as a director;
4.To hold an advisory (non-binding) vote to approve the compensation of the Company’s “named executive officers” as described in full in the “Executive Compensation Discussion and Analysis” section, the tabular disclosure regarding such compensation, and the accompanying narrative disclosure on pages 38 to 52 of the accompanying Proxy Statement;
5.To hold an advisory (non-binding) vote on the frequency of future advisory votes to approve the compensation of the Company’s “named executive officers”;
6.To appoint Ernst & Young LLP as auditors of the Company to hold office until the conclusion of the next general meeting at which annual accounts are laid before the Company and to authorize the Audit Committee of the Board of Directors of the Company to agree the auditors’ remuneration as described in full on pages 13 to 14 of the accompanying Proxy Statement;
7.To adopt and approve the proposed amendment to the Company’s 2020 Stock Incentive Plan as described on pages 15 to 22 of the accompanying Proxy Statement;
8.To generally and unconditionally authorize the Board of Directors (the “Board”) of the Company to exercise all powers of the Company to allot shares in the Company or grant rights to subscribe for or to convert any security into shares of the Company up to an aggregate nominal amount of ￡125,000,000 (being the aggregate nominal amount of ￡110,000,000 in respect of ordinary shares and ￡15,000,000 in respect of preference shares) as described in full on pages 23 to 24 of the accompanying Proxy Statement;
9.To, subject to the passing of Resolution No. 8, disapply statutory pre-emption rights otherwise applicable to shares in the Company allotted by the Board, up to an aggregate nominal amount of ￡125,000,000 (being the aggregate nominal amount of ￡110,000,000 in respect of ordinary shares and ￡15,000,000 in respect of preference shares) as described in full on pages 25 to 26 of the accompanying Proxy Statement.
|
| 2023-01-31 |
股东大会：
将于2023-02-28召开股东大会
会议内容 ▼▲
- 1.That Per Wold-Olsen be removed from office as a director of the Company with immediate effect;
2.That in the event any director is appointed after the Company’s receipt of the general meeting requisition notice dated January 10, 2023, and prior to the general meeting, each such director be removed from office as a director of the Company with immediate effect;
3.That Patrice Bonfiglio having consented to act, be appointed as an additional director of the Company with immediate effect;
4.That Paul Cohen, having consented to act, be appointed as an additional director of the Company with immediate effect;
5.That Mark DiPaolo, having consented to act, be appointed as an additional director of the Company with immediate effect;
6.That Keith L. Horn, having consented to act, be appointed as an additional director of the Company with immediate effect;
7.That Odysseas Kostas, having consented to act, be appointed as an additional director of the Company with immediate effect;
8.That Louis Sterling III, having consented to act, be appointed as an additional director of the Company with immediate effect;
9.That Diane E. Sullivan, having consented to act, be appointed as an additional director of the Company with immediate effect.
|
| 2022-05-24 |
股东大会：
将于2022-06-27召开股东大会
会议内容 ▼▲
- 1.To re-elect Mr. Karim Mikhail as a director;
2.To re-elect Mr. Per Wold-Olsen as a director;
3.To re-elect Ms. Erin Enright as a director;
4.To re-elect Mr. Alfonso Zulueta as a director;
5.To hold an advisory (non-binding) vote to approve the compensation of the Company’s “named executive officers” as described in full in the “Executive Compensation Discussion and Analysis” section, the tabular disclosure regarding such compensation, and the accompanying narrative disclosure on pages 34 to 49 of the accompanying Proxy Statement;
6.To appoint Ernst & Young LLP as auditors of the Company to hold office until the conclusion of the next general meeting at which accounts are laid before the Company and to authorize the Audit Committee of the Board of Directors of the Company to fix the auditors’ remuneration as described in full on pages 11 to 12 of the accompanying Proxy Statement;
7.To adopt and approve the proposed amendment to the Company’s 2020 Stock Incentive Plan as described on pages 13 to 21 of the accompanying Proxy Statement.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-29 |
股东大会：
将于2021-06-14召开股东大会
会议内容 ▼▲
- 1.To re-elect Mr. Patrick O’Sullivan as a director;
2.To re-elect Mr. David Stack as a director;
3.To hold an advisory (non-binding) vote to approve the compensation of the Company’s “named executive officers” as described in full in the “Executive Compensation Discussion and Analysis” section, the tabular disclosure regarding such compensation, and the accompanying narrative disclosure on pages 22 to 57 of the accompanying Proxy Statement;
4.To appoint Ernst & Young LLP as auditors of the Company to hold office until the conclusion of the next general meeting at which accounts are laid before the Company and to authorize the Audit Committee of the Board of Directors of the Company to fix the auditors’ remuneration as described in full on pages 10 to 11 of the accompanying Proxy Statement.
|
| 2020-06-01 |
股东大会：
将于2020-07-13召开股东大会
会议内容 ▼▲
- 1.To re-elect Dr. Lars G. Ekman as a director;
2.To re-elect Mr. Joseph S. Zakrzewski as a director;
3.To hold an advisory (non-binding) vote to approve the compensation of the Company’s “named executive officers” as described in full in the “Executive Compensation Discussion and Analysis” section, the tabular disclosure regarding such compensation, and the accompanying narrative disclosure on pages 30 to 62 of the accompanying Proxy Statement;
4.To appoint Ernst & Young LLP as auditors of the Company to hold office until the conclusion of the next general meeting at which accounts are laid before the Company and to authorize the Audit Committee of the Board of Directors of the Company to fix the auditors’ remuneration as described in full on pages 10 to 11 of the accompanying Proxy Statement;
5.To approve the Amarin Corporation plc 2020 Stock Incentive Plan as described in full on pages 12 to 19 of the accompanying Proxy Statement in advance of the expiration of the 2011 Plan (as defined below).
|
| 2019-04-25 |
股东大会：
将于2019-05-20召开股东大会
会议内容 ▼▲
- 1.To re-elect Mr. Jan van Heek as a director;
2.To re-elect Ms. Kristine Peterson as a director;
3.To hold an advisory (non-binding) vote to approve the compensation of the Company’s “named executive officers” as described in full in the “Executive Compensation Discussion and Analysis” section, the tabular disclosure regarding such compensation, and the accompanying narrative disclosure on pages 25 to 55 of the accompanying Proxy Statement;
4.To appoint Ernst & Young LLP as auditors of the Company to hold office until the conclusion of the next general meeting at which accounts are laid before the Company and to authorize the Audit Committee of the Board of Directors of the Company to fix the auditors’ remuneration as described in full on pages 9 to 10 of the accompanying Proxy Statement;
5.To generally and unconditionally reauthorize the Board of Directors of the Company to exercise all powers of the Company to allot shares in the Company or grant rights to subscribe for or to convert any security into shares of the Company up to an aggregate nominal amount of ￡148,000,000 (being the aggregate nominal amount of ￡125,000,000 in respect of ordinary shares and ￡23,000,000 in respect of preference shares) as described in full on pages 11 to 12 of the accompanying Proxy Statement;
6.To, subject to the passing of Resolution No. 5, disapply statutory pre-emption rights otherwise applicable to shares in the Company allotted by the Board of Directors, up to an aggregate nominal amount of ￡148,000,000 (being the aggregate nominal amount of ￡125,000,000 in respect of ordinary shares and ￡23,000,000 in respect of preference shares) as described in full on pages 13 to 14 of the accompanying Proxy Statement.
|
| 2018-04-20 |
股东大会：
将于2018-05-14召开股东大会
会议内容 ▼▲
- 1.To re-elect Mr. John F. Thero as a director;
2.To re-elect Mr. Patrick J. O’Sullivan as a director;
3.To hold an advisory (non-binding) vote to approve the compensation of the Company’s “named executive officers” as described in full in the “Executive Compensation Discussion and Analysis” section, the tabular disclosure regarding such compensation, and the accompanying narrative disclosure on pages 21 to 38 and pages 39 to 49 of the accompanying Proxy Statement;
4.To appoint Ernst & Young LLP as auditors of the Company to hold office until the conclusion of the next general meeting at which accounts are laid before the Company and to authorize the Audit Committee of the Board of Directors of the Company to fix the auditors’ remuneration as described in full on pages 9 to 10 of the accompanying Proxy Statement.
|
| 2017-04-21 |
股东大会：
将于2017-05-15召开股东大会
会议内容 ▼▲
- 1.To re-elect Dr. Lars Ekman as a director;
2.To re-elect Mr. David Stack as a director;
3.To hold an advisory (non-binding) vote to approve the compensation of the Company’s “named executive officers” as described in full in the “Compensation Discussion and Analysis” section, the tabular disclosure regarding such compensation, and the accompanying narrative disclosure on pages 33 to 51 and 53 to 60 of the accompanying Proxy Statement;
4.To hold an advisory (non-binding) vote on the frequency of future advisory votes to approve the compensation of the Company’s “named executive officers”;
5.To appoint Ernst & Young LLP as auditors of the Company to hold office until the conclusion of the next general meeting at which accounts are laid before the Company and to authorize the Audit Committee of the Board of Directors of the Company to fix the auditors’ remuneration as described in full on pages 10 to 11 of the accompanying Proxy Statement;
6.To adopt and approve the proposed amendment to the Company’s 2011 Stock Incentive Plan as described on pages 12 to 19 of the accompanying Proxy Statement;
7.To adopt and approve the proposed Amarin Corporation plc 2017 Employee Stock Purchase Plan as described on pages 20 to 22 of the accompanying Proxy Statement.
|
| 2016-04-29 |
股东大会：
将于2016-07-11召开股东大会
会议内容 ▼▲
- 1.To re-elect Ms. Kristine Peterson as a director;
2.To re-elect Mr. Joseph S. Zakrzewski as a director;
3.To hold an advisory (non-binding) vote to approve the compensation of the Company’s “named executive officers” as described in full in the “Compensation Discussion and Analysis” section, the tabular disclosure regarding such compensation, and the accompanying narrative disclosure on page 9 and pages 22 to 49 of the accompanying Proxy Statement;
4.To appoint Ernst & Young LLP as auditors of the Company to hold office until the conclusion of the next general meeting at which accounts are laid before the Company and to authorize the Audit Committee of the Board of Directors of the Company to fix the auditors’ remuneration as described in full on pages 10 to 11 of the accompanying Proxy Statement.
|